However, CDH1 mutations are connected to an aggressive BC pattern characterized by lymphovascular invasion and axillary lymph node metastases, particularly within Invasive Lobular Carcinoma (ILC), which accounts for 5–15% of BC cases and is linked to CDH1 loss of function mutations [46, 47]. Here, CDH1 is linked to breast cancer.